Approval · Notice of Compliance 14941 · 2013
AZITHROMYCIN: Notice of Compliance 14941
Issued November 26, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14941
- Date
- November 26, 2013
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Product name change
- Therapeutic class
- Antibiotic
- Canadian reference product
- ZITHROMAX (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AZITHROMYCIN | 02274388 | Cancelled Post Market |
| AZITHROMYCIN | 02274396 | Cancelled Post Market |
Medicinal ingredients
- AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE 100 MG per 5ML
- AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE 200 MG per 5ML